Abstract:Background Coronary artery disease (CAD) is the leading cause of mortality and morbidity worldwide. In addition to diagnosis, non-invasive tests may also provide prognostic information useful in the risk stratification and management of CAD patients. Stress echocardiography (SE) is an accurate, non-invasive method for the detection of obstructive CAD. However, in real-world clinical practice the test performance may vary among different centres, depending on availability, local protocols, and operator expertise. Purpose To evaluate the prognostic value of contrast SE in a real-world population of symptomatic patients without known CAD. Methods This was a cohort follow-up study of patients without known CAD and symptoms of atypical chest pain, unexplained dyspnoea or palpitations who were referred to the echocardiography lab of a tertiary hospital for SE between January 2020 and December 2021. Patients with resting regional wall motion abnormalities were excluded. All patients underwent treadmill exercise stress echocardiography (ESE) or dobutamine stress echocardiography (DSE) if unable to exercise. Contrast agents were used in almost all patients (99%). The study population was followed-up for at least 2 years after SE by phone and/or electronic hospital records. Cardiac outcome was defined as anatomically or functionally significant stenosis on angiography, revascularization, acute coronary syndrome (ACS), or cardiac-related death. Results The study comprised 266 patients (mean age 58±12 years, 63% male) who underwent either ESE (58%) or DSE (42%). The patients' details are reported in Table 1. The most common indication for the exam was atypical chest pain, with a prevalence of 73%. SE exams were positive for inducible ischaemia in 14 (5%) patients. Symptoms during the exam were present in 3 (21%) patients with positive SE and 4 patients (2%) with negative SE (p=0.004). No serious complications (sustained ventricular tachycardia, myocardial infarction, or death) were recorded. During the follow-up (median 30, IQR 23–38 months), 264 patients (99%) were successfully contacted. Cardiac outcome occurred in 10 patients. Among 14 patients with positive SE, 8 underwent revascularization due to significant coronary artery stenosis. Among 250 patients with negative SE, 1 underwent revascularization due to significant coronary artery stenosis and 1 presented with ACS 13 months after the test (both patients underwent DSE). Negative predictive value was 99% over a median follow-up of 30 months, corresponding to an annualized event rate of 0.32% per year. A positive SE was significantly associated with cardiac outcome (log-rank test p<0.0001, Figure 1). Conclusion Contrast SE carries significant prognostic implications in symptomatic patients without known CAD. A positive test is strongly associated with the need for revascularization, while a normal test result has an excellent negative predictive value regarding cardiovascular morbidity and mortality.Figure 1

Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population

The diagnostic and prognostic value of exercise electrocardiography in asymptomatic subjects and stable symptomatic patients

Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study

Cardiac CT findings in patients with family history of premature CAD: an observational study

Clinical and Angiographic Significance of a Normal Thallium-201 Tomographic Study in Patients With a Strongly Positive Exercise Electrocardiogram

Exercise Tolerance Testing To Screen for Coronary Heart Disease: A Systematic Review for the Technical Support for the U.S. Preventive Services Task Force

Future applications of incidental detection of thoracic and coronary calcium for atherosclerotic cardiovascular disease events prediction

Value of Exercise ECG for Risk Stratification in Suspected or Known CAD in the Era of Advanced Imaging Technologies

Prognostic Value of Thallium-201 Myocardial Perfusion Single Photon Emission Computed Tomography in Aircrew with Silent Coronary Artery Disease

Prognostic Value of Normal Exercise 99Mtc-Sestamibi Myocardial Tomography in Patients with Angiographic Coronary Artery Disease.

Refining Cardiovascular Calcification in the Appraisal of Ischemic Heart

Exercise Electrocardiography Testing in Patients with Calcific Non-obstructive Coronary Lesions at Cardiac Multislice Computed Tomography

Noninvasive assessment of cardiac risk in insulin‐dependent diabetic patients being evaluated for pancreatic transplantation using thallium‐201 myocardial perfusion scintigraphy

Prognostic Relevance of Ischemic Late Gadolinium Enhancement in Apparently Healthy Endurance Athletes: A Follow-up Study Over 5 years

Reducing radiation dose from myocardial perfusion imaging in subjects with complex congenital heart disease

Improvement in the efficacy of exercise first-pass radionuclide angiocardiography in detecting coronary artery disease and the effect of patient age

Quantitative electrocardiographic measures and long-term mortality in exercise test patients with clinically normal resting electrocardiograms

The prognostic value of contrast stress echocardiography in a real-world population of symptomatic patients without known coronary artery disease

Cardiac transthyretin amyloidosis in patients with conduction system disease

Low Utilization Of Nuclear Scintigraphy For Cardiac Amyloidosis Evaluation Among Patients With Aortic Stenosis Referred For Transcatheter Aortic Valve Replacement

Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial